Search Result
List
2018-07-30 - 2020-09-30
Phase III
-
Condition/Disease
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer Metastatic Gastric Adenocarcinoma or Cancer Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
-
Test Drug
Zolbetuximab (IMAB362)
Participate Sites
9Sites
Recruiting6Sites
Terminated1Sites
2018-12-01 - 2027-12-31
Phase II/III
-
Condition/Disease
Non-Small Cell Lung Cancer
-
Test Drug
Bevacizumab GDC-6036、Docetaxel Tencentriq、Carboplatin-GRY、Cisplatin NeoCorp、Gitrabin、Alimta、Entrectinib
Participate Sites
4Sites
Recruiting4Sites
2017-03-01 - 2019-12-31
Phase III
-
Condition/Disease
Triple Negative Breast Neoplasms
-
Test Drug
學名：Pembrolizumab (MK-3475) ；商品名：KEYTRUDA®/吉舒達®
Participate Sites
6Sites
Terminated6Sites
Division of Hematology & Oncology
2017-01-20 - 2025-08-15
Phase III
-
Condition/Disease
Head and Neck Neoplasms
-
Test Drug
Keytruda
Participate Sites
7Sites
Terminated7Sites
Division of Radiation Therapy
2017-01-17 - 2020-09-30
Phase III
-
Condition/Disease
Gastric Cancer,Gastroesophageal Junction Cancer
-
Test Drug
Nivolumab/Ipilimumab/Oxaliplatin/Fluorouracil/Leucovorin/Capecitabine
Participate Sites
2Sites
Terminated1Sites
Study ended1Sites
Division of Hematology & Oncology
2018-03-16 - 2024-12-05
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
6Sites
Terminated5Sites
2018-12-30 - 2024-12-31
Phase I
-
Condition/Disease
-
Test Drug
Participate Sites
7Sites
Recruiting4Sites
Terminated1Sites
2015-10-01 - 2020-06-30
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
6Sites
Recruiting3Sites
Terminated3Sites
Division of Hematology & Oncology
Division of Hematology & Oncology
2019-01-01 - 2024-08-27
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
4Sites
Recruiting3Sites
